FDA Inspection 1211561 — Arrow International, Inc. (Subsidiary of Teleflex, Inc.)

Arrow International, Inc. (Subsidiary of Teleflex, Inc.) — FEI 3015859709

The FDA completed an inspection of Arrow International, Inc. (Subsidiary of Teleflex, Inc.) on July 14, 2023 in Wyomissing, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 14, 2023
Fiscal Year
2023
Product Type
Devices
Project Area
Compliance: Devices
Location
Wyomissing, PA (United States)